Company intelligence / Profile preview
BWXT Medical
- Ownership
- Private
- Employees
- ~300
- Development stage
- Other
Overview
BWXT Medical develops, manufactures, and supplies medical isotopes and radiopharmaceuticals used globally in diagnostic imaging and targeted radiotherapy. The company has a commercial portfolio including contract manufacturing of devices like TheraSphereTM for liver cancer. Its proprietary technetium‑99m generator technology has been submitted to the FDA for approval. The company also supports clinical trials with therapeutic radioisotopes such as actinium‑225.
- Therapeutic areas
- OncologyOther
- Modalities
- RadiopharmaceuticalActive pharmaceutical ingredientDevice
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on BWXT Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BWXT Medical.